Profound Medical Corp. (PROF)
6.96
-0.02
(-0.29%)
USD |
NASDAQ |
Feb 20, 16:00
6.92
-0.04
(-0.57%)
After-Hours: 20:00
Profound Medical EPS Diluted (Quarterly) : -0.265 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | 0.0207 |
| Quest Diagnostics, Inc. | 2.18 |
| CytoSorbents Corp. | -0.0505 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0046 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.977M |
| Revenue (Quarterly) | 5.289M |
| Total Expenses (Quarterly) | 13.27M |
| Enterprise Value | 232.53M |
| Gross Profit Margin (Quarterly) | 74.32% |
| Profit Margin (Quarterly) | -150.8% |
| Earnings Yield | -19.20% |
| Normalized Earnings Yield | -19.20 |